Efficacy of miltefosine (Impavido®) for mucocutaneous leishmaniasis in Bolivia

被引：0
|
作者：
Soto, Jaime [1 ]
Toledo, Julia [1 ]
Parra, Rolando [2 ]
Balderrama, Margarita [2 ]
Rea, Jaime [2 ]
Gomez, Ana [3 ]
Ardiles, Jaime [4 ]
Soto, Paula
Valda, Luis [4 ]
Sindermann, Herbert [5 ]
Anders, Gerlind [5 ]
Engel, Jurgen [5 ]
Berman, Jonathan [6 ]
机构：
[1] FADER Cibic, Bogota, Colombia
[2] Proyecto Oscar, Palos Blancos, Bolivia
[3] Hosp Local, Palos Blancos, Bolivia
[4] Hosp Clin, La Paz, Bolivia
[5] Zentaris AG, Frankfurt, Germany
[6] ABF, Rockville, MD USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2005年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1053
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [1] Miltefosine (Impavido®) in the treatment of mucocutaneous and cutaneous leishmaniasis in Bolivia
    Toledo, Julia
    Soto, Jaime
    Soto, Paula
    Balderama, Margarita
    Rea, Ivan
    Gomez, Ana
    Soto, Jaime
    Parra, Rolando
    Valda, Luis
    Guillen, Ninoshtka
    Anders, Gerlind
    Sindermann, Herbert
    Engel, Jurgen
    Berman, Jonathan
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 297 - 297
  • [2] Efficacy of miltefosine (Impavido®) for cutaneous leishmaniasis in Colombia
    Soto, Jaime
    Toledo, Julia
    Soto, Paula
    Padilla, Julio
    Sindermann, Herbert
    Anders, Gerlind
    Engel, Jurgen
    Berman, Jonathan
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 73 - 74
  • [3] Miltefosine (Impavido) for Leishmaniasis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 89 - 90
  • [4] Efficacy and tolerability of oral miltefosine (Impavido®) in patients with resistant visceral leishmaniasis
    Engel, KR
    Sindermann, H
    Fischer, C
    Bommer, W
    Multidisciplinarity for Parasites, Vectors and Parasitic Diseases, Vol 2, 2004, : 57 - 61
  • [5] Miltefosine (Impavido): the first oral treatment against leishmaniasis
    H. Sindermann
    S. L. Croft
    K. R. Engel
    W. Bommer
    H. J. Eibl
    C. Unger
    J. Engel
    Medical Microbiology and Immunology, 2004, 193 : 173 - 180
  • [6] Miltefosine (Impavido): the first oral treatment against leishmaniasis
    Sindermann, H
    Croft, SL
    Engel, KR
    Bommer, W
    Eibl, HJ
    Unger, C
    Engel, J
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2004, 193 (04) : 173 - 180
  • [7] Impavido® (INN: miltefosine) -: first oral therapy of leishmaniasis
    不详
    INFECTION, 2005, 33 (03) : 181 - 182
  • [8] IMPAVIDO™ (MILTEFOSINE) FOR ANNERGIC DIFFUSE CUTANEOUS LEISHMANIASIS, A RARE AND INTRACTABLE DISEASE
    Hueb, M.
    Oliveira, T. F.
    Grigoli, E.
    Viana, T. R.
    Proenca, W. B.
    Damin, B. C.
    Fonseca-Jr, E. A.
    Carvalho, A. P.
    Cavalcante, L. R. S.
    Reis, P., V
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 : S154 - S154
  • [9] Short Report: Efficacy of Extended (Six Weeks) Treatment with Miltefosine for Mucosal Leishmaniasis in Bolivia
    Soto, Jaime
    Rea, Jaime
    Valderrama, Margarita
    Toledo, Julia
    Valda, Luis
    Ardiles, Jaime
    Berman, Jonathan
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (03): : 387 - 389
  • [10] RURAL CAMPAIGN TO DIAGNOSE AND TREAT MUCOCUTANEOUS LEISHMANIASIS IN BOLIVIA
    DEDET, JP
    MELOGNO, R
    CARDENAS, F
    VALDA, L
    DAVID, C
    FERNANDEZ, V
    TORREZ, ME
    DIMIERDAVID, L
    LYEVRE, P
    VILLAREAL, ME
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1995, 73 (03) : 339 - 345
12345